Posters and Publications on our ExPlain Analysis System
- Identification of dominant signaling pathways from proteomics expression data.
Zubarev RA*, Nielsen ML*, Fung EM*, Savitski MM*<//a>, Kel-Margoulis O, Wingender E, Kel A.
*Division of Molecular Biometry, Institute for Cell and Molecular Biology, Uppsala University, SE-75 124 Uppsala, Sweden.
[PubMed Link]
- Predicting signaling networks upon inflammation caused by PAR-1/ F2R activation: application of the ExPlain™ Analysis Platform.
Dinesh Madhyastha, Neetu Tandon, Mangala Sathyamurthy, Tatiana Konovalova, Volker Matys, Olga Kel-Margoulis, Alexander Kel
[PDF, ~700K] - Presented at HUGO India 2008
- Analysis of HER2/neu as a diagnostic bomarker using ExPlain™ to examine signaling pathways and transcription factors.
Michael N. Liebman*, Brenda Deyarmin*, Craig D. Shriver*, Philip Stegmaier, Holger Karas, Alexander Kel and Edgar Wingender
*Non-BIOBASE Personnel
[Abstract] [PDF 265K] - Presented at ISMB Vienna 2007
- ExPlain™: Finding molecular mechanism of disease from promoter models to signaling pathways.
Alexander Kel, Nico Voss, Tanyana Konovalova, Philip Stegmaier, Olga Kel-Margoulis, Tagir Waleev*, Gerd Schmitz*, Edgar Wingender
*Non-BIOBASE personnel
[Abstract] [PDF 792K] - Presented at ISMB Vienna 2007
- Regulatory modeling of epidermal growth factor-induced carcinogenicity
Philip Stegmaier, Alexander Kel, Edgar Wingender, and Juergen Borlak*
*Non-BIOBASE personnel
[Abstract] [PDF 253K] - Presented at ISMB Vienna 2007
- A bioinformatics approach to analyze intracellular events upon treatment of cancer cells with a chemotherapeutic drug.
Dinesh Madhyastha, Jesintha Maniraja, Raghavendra Prasad, Olga Kel-Margoulis, and Alexander Kel.
[Abstract] [PDF] - Presented at Bangalore BIO 2007
Top